Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Oslo Børs is the primary stock exchange for Norway, providing a regulated marketplace for the trading of shares, bonds, and other financial instruments. Established in 1818, it serves as a central hub for the Norwegian capital market and is particularly recognized for its global leadership in the energy, shipping, and seafood sectors. While not a life sciences company itself, it is a significant listing venue for Nordic biotechnology and healthcare companies seeking public capital. Since June 2019, Oslo Børs has been a subsidiary of Euronext, the leading pan-European market infrastructure.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Oslo Børs.